Patrice Petit | Cell Biology | Research Excellence Award

Published on by Molecular Biologist

Research Excellence Award

                Patrice Petit
Researcher Patrice Petit
Affiliation French National Centre for Scientific Research
Country France
Scopus ID 7202461475
Documents 91
Citations 10,021
h-index 43
Subject Area Cell Biology
Event International Molecular Biologist Awards
ORCID 0000-0002-5038-9101
Google Scholar lXSsj1UAAAAJ

Patrice Petit

French National Centre for Scientific Research, France

Patrice Petit is a researcher affiliated with the French National Centre for Scientific Research whose scholarly profile is associated with Cell Biology. The supplied bibliometric record reports 91 documents, 10,021 citations, and an h-index of 43, providing quantitative indicators of research visibility and scholarly influence .The Research Excellence Award recognizes sustained scholarly achievement, research productivity, and contributions that advance scientific knowledge within a defined field.[1][2]

Abstract

Patrice Petit has developed a substantial scholarly record in the field of Cell Biology, with a publication portfolio of 91 documents and a reported citation count of 10,021. An h-index of 43 indicates that a significant portion of the research output has received sustained scholarly attention. These indicators provide quantitative evidence of research visibility and form one component of a broader academic assessment that may also consider scientific originality, methodological quality, collaboration, and contribution to the field.[1][2]

Keywords

Patrice Petit, Research Excellence Award, Cell Biology, French National Centre for Scientific Research, CNRS, scientific research, scholarly publications, citation impact, h-index, research productivity, molecular biology, academic recognition.

Introduction

Cell Biology investigates the structural, functional, molecular, and physiological processes that govern living cells. Research in this discipline contributes to understanding cellular organization, signaling, metabolism, development, disease mechanisms, and interactions between cells and their environments. Contemporary cell biology frequently intersects with molecular biology, biochemistry, genetics, microscopy, genomics, and biomedical sciences.

Academic research performance is commonly evaluated through a combination of qualitative and quantitative indicators. Publication records, citation counts, and the h-index can provide useful bibliometric information, although such measures should be interpreted in relation to disciplinary practices and research context rather than treated as independent measures of scientific quality.[3]

Research Profile

The supplied academic profile identifies Patrice Petit with the French National Centre for Scientific Research in France and places the research specialization within Cell Biology. The associated Scopus author record is identified by Author ID 7202461475. The reported publication and citation indicators provide a snapshot of the researcher’s indexed scholarly activity.[1]

  • Affiliation: French National Centre for Scientific Research.
  • Country: France.
  • Primary subject area: Cell Biology.
  • Scopus documents: 91.
  • Reported citations: 10,021.
  • Reported h-index: 43.

Research Contributions

Research in Cell Biology contributes to the understanding of cellular mechanisms and their relationship to broader biological systems. Within this scientific context, a researcher’s contribution can be assessed through the quality and relevance of published studies, methodological advances, collaboration, reproducibility, and the extent to which findings are used by subsequent research. The available profile data support the presence of an established publication and citation record, while detailed assessment of individual contributions requires examination of the underlying publications.[1][3]

The affiliation with a major national research organization provides an institutional context for scientific investigation and collaboration. The reported research metrics suggest that the associated body of work has been referenced by other researchers over an extended scholarly period, although citation-based measures alone cannot establish the significance or originality of individual findings.[2]

Publications

The supplied Scopus information records 91 scholarly documents associated with Patrice Petit. These documents constitute the indexed publication component of the research profile and provide a basis for evaluating publication productivity. The complete publication portfolio should be examined through the researcher’s bibliographic profiles when evaluating individual articles, journals, co-authorship patterns, and subject-specific contributions.[1]

  • Indexed publication output: 91 documents.
  • Reported citation count: 10,021.
  • Reported h-index: 43.
  • Research area represented in the supplied profile: Cell Biology.

Research Impact

The reported citation count of 10,021 indicates substantial scholarly referencing of the indexed research output, while an h-index of 43 indicates that at least 43 publications have each received at least 43 citations under the metric definition of the h-index.[3] Citation counts can vary between databases because indexing coverage, author disambiguation, document types, and update schedules differ. Consequently, the figures presented on this page should be understood as a profile snapshot rather than a permanent measure of research performance.[1][2]

Research impact is broader than bibliometric indicators. Qualitative assessment may consider scientific originality, conceptual contribution, methodological rigor, reproducibility, collaboration, influence on subsequent studies, and practical or societal relevance. A balanced award assessment therefore benefits from combining bibliographic evidence with expert review.[3]

Award Suitability

The supplied academic indicators provide several elements relevant to consideration for a Research Excellence Award. The profile combines an established publication record with a reported citation count of more than ten thousand and an h-index of 43. These measures can serve as quantitative evidence of sustained scholarly visibility within the research literature.[1]

Final award suitability should nevertheless be determined through the applicable award criteria and, where appropriate, independent academic review. Bibliometric indicators can support an evaluation but should not be interpreted as a substitute for assessment of the scientific content, originality, rigor, and broader significance of the research.[3]

Conclusion

Patrice Petit is presented in the supplied scholarly profile as a Cell Biology researcher affiliated with the French National Centre for Scientific Research in France. The reported record of 91 documents, 10,021 citations, and an h-index of 43 provides measurable evidence of an established research presence. These indicators, together with qualitative examination of scientific contributions, can form part of a structured evaluation for research recognition.[1][3]

References

  1. Elsevier. (n.d.). Scopus author details: Patrice Petit, Author ID 7202461475. Scopus.
    https://www.scopus.com/pages/authors/7202461475
  2. Google Scholar. (n.d.). Scholar profile of Patrice Petit. Google Scholar.
    https://scholar.google.com/citations?user=lXSsj1UAAAAJ&hl=fr
  3. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences, 102(46), 16569–16572.
    https://doi.org/10.1073/pnas.0507655102
  4. ORCID. (n.d.). ORCID record: Patrice Petit. ORCID.
    https://orcid.org/0000-0002-5038-9101
  5. International Molecular Biologist Awards. (n.d.). Official Award Website.
    https://molecularbiologist.org/

Faiz Ali Khan | Cell Biology | Molecular Biology Contribution Award

Published on by Molecular Biologist

Dr. Faiz Ali Khan | Cell Biology | Molecular Biology Contribution Award 

Postdoc researcher, at Fudan University, China.

Dr. Faiz Ali Khan, Ph.D., is an accomplished scientist in cell and molecular biology with over 10 years of research experience in cancer biology, genetics, and RNA-mediated regulation. Currently serving as a Postdoctoral Researcher at Fudan University, China, he previously worked at Shaukat Khanum Memorial Cancer Hospital and Research Center in Pakistan, where he led impactful research on tumor suppressor genes, oncogenes, and RNA modifications. Dr. Khan is known for integrating advanced molecular biology techniques with clinical applications, particularly in cancer therapeutics. His work has contributed to the understanding of cancer progression mechanisms and molecular markers. He possesses strong expertise in RNA-protein interactions, gene expression regulation, and proteomics, and collaborates internationally. He is driven by the goal of translating scientific discoveries into diagnostic and therapeutic breakthroughs. With multiple peer-reviewed publications, international fellowships, and prestigious awards, Dr. Khan is a recognized voice in the field of molecular oncology.

Professional Profile

Scopus

ORCID

Google Scholar

🎓 Education 

Dr. Faiz Ali Khan holds a Ph.D. in Biochemistry & Molecular Biology from Henan University, China (2019–2023), supported by the Chinese Government Doctoral Scholarship. His doctoral research focused on the role of RNA-binding proteins and mRNA degradation in cancer progression. Prior to this, he earned an M.Phil. (2011) and M.Sc. (2008) in Genetics from Hazara University, Pakistan, where he explored genetic polymorphisms and cancer susceptibility. His academic journey began with a B.Sc. in Biology from the University of Malakand (2005), where he cultivated a passion for understanding genetic mechanisms. Throughout his education, Dr. Khan has demonstrated excellence in both coursework and laboratory research, receiving recognition for his dedication and academic contributions. His cross-disciplinary foundation bridges genetics, molecular biology, and biotechnology, equipping him with robust capabilities to tackle biomedical challenges. His research training spans across Asia, offering a global perspective on translational medicine and life science innovation.

🧪 Experience 

Dr. Faiz Ali Khan currently works as a Postdoctoral Researcher at the Institute of Integrative Medicine, Fudan University, Shanghai, where he studies oncogene modulation and RNA dynamics in tumor cells. From 2013 to 2018, he was a Research Associate at the Basic Science Research Lab of Shaukat Khanum Memorial Cancer Hospital, Lahore, a premier oncology institute. There, he led numerous projects involving molecular genetics, cellular assays, and xenograft models, focusing on breast and esophageal cancers. Earlier, he served as a Research Fellow (2011–2012) in the same institution, gaining hands-on experience in genetic screening, transfection techniques, and epigenetic profiling. His technical expertise includes RNA-IP, ChIP, Western blotting, flow cytometry, DHPLC, and more. Dr. Khan has also mentored junior researchers and collaborated on large-scale genomics studies. His extensive background in laboratory research and clinical correlation has greatly contributed to advancing cancer molecular diagnostics and precision medicine.

🔬 Research Interests 

Dr. Faiz Ali Khan’s research interests revolve around the molecular mechanisms underlying cancer progression, especially the roles of RNA-binding proteins (e.g., FXR1), epigenetic modulators, and RNA methylation (m6A). He investigates how non-coding RNAs, pseudogenes, and circRNAs influence gene expression, chromatin remodeling, and tumorigenesis. His work also focuses on understanding the dynamics of oncogene and tumor suppressor gene regulation, utilizing tools like RNA immunoprecipitation, ChIRP, and real-time PCR. Dr. Khan is particularly interested in translating basic science findings into potential therapeutic targets, such as identifying phytochemicals (e.g., Icariside II) for treating asthma and cancer. Additionally, he explores liquid phase separation in epigenetics, protein-protein interactions, and molecular markers for early cancer detection. His interdisciplinary approach combines biochemistry, proteomics, and genomics to advance personalized medicine. By bridging lab-based experiments with clinical relevance, Dr. Khan contributes meaningfully to biomedical innovation and cancer treatment strategies.

🏆 Awards 

Dr. Faiz Ali Khan has been recognized for his scientific excellence and research contributions throughout his career. In 2024, he was appointed as a Postdoctoral Researcher at Fudan University, supported by China’s prestigious Doctoral Talent Program. His Ph.D. at Henan University (2018–2023) was fully funded by the Chinese Government Doctoral Scholarship, a competitive international award. In 2017, Dr. Khan was honored with the Employee of the Year Award at Shaukat Khanum Memorial Cancer Hospital, acknowledging his dedication to cancer research and team leadership. Additionally, he has received multiple nominations for his contributions to translational oncology and molecular diagnostics. Dr. Khan’s accolades reflect his commitment to innovation, ability to manage complex projects, and contribution to global cancer research initiatives. These achievements underscore his reputation as a leading young scientist in the fields of genetics, molecular biology, and oncology.

📚Top Noted Publications 

Dr. Faiz Ali Khan has authored numerous high-impact publications across oncology, molecular biology, and genetics:

1. FXR1 and Esophageal Cancer Progression

  • Authors: [Author details not available]

  • Journal: Biology Direct

  • Year: 2024

  • Citation Count: 8

  • DOI: [DOI not available]​PubMed CentralFrontiers+4Frontiers+4Frontiers+4

2. MRPS23 in Breast Cancer

  • Authors: [Author details not available]

  • Journal: Cellular and Molecular Biology

  • Year: 2024

  • Citation Count: 6

  • DOI: [DOI not available]​

3. m6A Methylation and Diseases

  • Authors: [Author details not available]

  • Journal: Cancer Gene Therapy

  • Year: 2024

  • Citation Count: 9

  • DOI: [DOI not available]​PubMed CentralPubMed Central+5Frontiers+5Frontiers+5SpringerLink

4. FXR1P in Cancer: A Review

  • Authors: [Author details not available]

  • Journal: Cell Death & Disease

  • Year: 2024

  • Citation Count: 14

  • DOI: [DOI not available]​

5. FANCM Variants in Breast/Ovarian Cancer

  • Authors: Rashid MU, Muhammad N, Shehzad U, et al.

  • Journal: Familial Cancer

  • Year: 2023

  • Citation Count: 5

  • DOI: 10.1007/s10689-022-00304-1​SpringerLinkPubMed Central+1NCBI+1

6. circRNAs in Cancer

  • Authors: [Author details not available]

  • Journal: Gene and Protein Disease

  • Year: 2022

  • Citation Count: 4

  • DOI: [DOI not available]​PubMed CentralSpringerLink

7. Pseudogenes in Epigenetics

  • Authors: [Author details not available]

  • Journal: Frontiers in Oncology

  • Year: 2022

  • Citation Count: 10

  • DOI: [DOI not available]​

8. circRNA-Encoded Proteins

  • Authors: [Author details not available]

  • Journal: Frontiers in Oncology

  • Year: 2022

  • Citation Count: 11

  • DOI: [DOI not available]​

9. Processing Body in Cancer

  • Authors: [Author details not available]

  • Journal: Molecular and Cellular Biochemistry

  • Year: 2022

  • Citation Count: 7

  • DOI: [DOI not available]​PubMed CentralFrontiers+3Frontiers+3Frontiers+3

10. Vitamin D Polymorphism and Breast Cancer

  • Authors: [Author details not available]

  • Journal: PLoS ONE

  • Year: 2015

  • Citation Count: 20

  • DOI: [DOI not available]​SpringerLink+9PubMed Central+9Frontiers+9

Conclusion

Dr. Faiz Ali Khan is highly suitable for the Research for Molecular Biology Contribution Award. His technical depth, publication record, and innovative contributions to cancer molecular biology firmly position him as a strong candidate. With minor enhancements in visibility and leadership narratives, his profile could match or surpass international standards for such honors.